Better Therapeutics (NASDAQ:BTTX) reported quarterly losses of $(0.41) per share which missed the analyst consensus estimate of $(0.38) by 7.89 percent. This is a 24.07 percent increase over losses of $(0.54) per share from the same period last year.
Morgan Stanley Maintains Equal-Weight on Amphenol, Raises Price Target to $83
Morgan Stanley maintains Amphenol (NYSE:APH) with a Equal-Weight and raises the price target from $80 to $83.
